Colchicine for children with pericarditis: systematic review of clinical studies

Samer Alabed1, Giordano Pérez-Gaxiola2, Amanda Burls3

  • 1Academic Radiology Registrar at Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.

Insights

Evidence for colchicine in pediatric pericarditis is limited. This systematic review found insufficient data to support or refute its use in children, highlighting the need for randomized controlled trials (RCTs).

Area of Science:

  • Pediatric Cardiology
  • Pharmacology
  • Systematic Reviews

Background:

  • Pericarditis is inflammation of the pericardium, a condition that can affect children.
  • Colchicine is an established treatment for pericarditis in adults.
  • The use of colchicine in pediatric patients with pericarditis is not routine due to limited evidence.

Purpose of the Study:

  • To systematically review existing evidence on the efficacy and safety of colchicine for treating pericarditis in children.
  • To identify the current state of research regarding colchicine's role in pediatric pericarditis management.

Main Methods:

  • A systematic review of observational and experimental human studies was conducted.
  • Searches were performed across multiple databases (Cochrane Central, Medline, EMBASE, LILACS) up to June 2015.
  • Data extraction and quality assessment were performed by two authors using the Cochrane risk of bias tool for non-randomised trials.

Main Results:

  • The review included 11 studies (2 case series, 9 case reports) involving 86 children with pericarditis.
  • Five articles (74 patients) suggested colchicine may prevent pericarditis recurrences.
  • Six studies (12 patients) indicated colchicine did not prevent recurrences.

Conclusions:

  • No randomized controlled trials (RCTs) were identified in the review.
  • There is insufficient evidence to either support or discourage the use of colchicine in children with pericarditis.
  • Large, double-blind RCTs are necessary to determine the efficacy and safety of colchicine in pediatric pericarditis.
Abstract

Related Concept Videos

Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
491
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
537
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
613
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
713
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
312
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
483